Could cause temporary or reversible harm; serious harm is unlikely.
Subpotent Drug
| Brand name | LEVOTHYROXINE SODIUM |
| Generic name | LEVOTHYROXINE SODIUM |
| Active ingredient(s) | LEVOTHYROXINE SODIUM |
| Distributed by / for | Macleods Pharma USA, Inc., Princeton, NJ |
| NDC | 33342-401-44 |
| Full product label | Levothyroxine Sodium Tablets USP 150 mcg, 1000 Tablets bottle, Rx Only, Manufactured for: Macleods Pharma USA, Inc., Princeton, NJ, Manufactured by: Macleods Pharmaceuticals Ltd., Sarigam, Valsad, Guajarat, INDIA NDC 33342-401-44 |
| Recalling firm | MACLEODS PHARMA USA, INC |
| Distribution | Nationwide |
| Quantity | 1315 bottles |
| Recall initiated | 2026-02-26 |
| Report date | 2026-04-01 |
| Recall completed | — |
| Recall number | D-0403-2026 |
| Classification | Class II |
| FDA status | Ongoing |
| Origin on file | Princeton NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗